# TEVA PHARMACEUTICAL INDUSTRIES LTD
> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
## Record
| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/teva-pharmaceutical-industries-ltd |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 53 |
| Claims under review | 2 |
| Evidence records | 13 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-24T04:45:10.88591+00:00 |
| Last reviewed | 2026-10-24T04:45:10.88591+00:00 |
## Identity
- Legal name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- Display name: TEVA PHARMACEUTICAL INDUSTRIES LTD
## Alpha Governance Record
| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-24T23:42:38.446806+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.807 |
| Directors | 10 |
| Committees | 13 |
| Governance events | 25 |
| Entity class | public_company |
## Section coverage
| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |
## Board
- Amir Elstein: Director. Status: current. Independent: true. Since: 2009-01-01. Committees: Audit (member); Corporate Governance and Nominating (member); Corporate Governance and Nominating; Audit; Finance and Investment (member); Finance and Investment (member). claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:9
- Chen Lichtenstein: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Audit (member); Audit; Compliance; Finance and Investment (member); Compliance (member); Finance and Investment (member). claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:10
- Gerald Lieberman: Director. Status: current. Independent: true. Since: 2015-01-01. Committees: Audit (chair); Audit · Chair; Human Resources and Compensation; Finance and Investment (member); Finance and Investment (member); Human Resources and Compensation (member). claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:11
- Perry D. Nisen: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Compliance (member); Human Resources and Compensation (member); Science and Technology (member); Science and Technology; Compliance; Human Resources and Compensation (member). claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:12
- Prof. Ronit Satchi-Fainaro: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Compliance (member); Compliance; Science and Technology; Corporate Governance and Nominating (member); Corporate Governance and Nominating (member); Science and Technology (member). claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:13
- Richard Francis: Director. Status: current. Independent: false. Since: 2023-01-01. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:14
- Roberto Mignone: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Audit (member); Corporate Governance and Nominating (chair); Corporate Governance and Nominating · Chair; Finance and Investment; Audit (member); Finance and Investment (member). claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:15
- Rosemary A. Crane: Director. Status: current. Independent: true. Since: 2015-01-01. Committees: Human Resources and Compensation (chair); Human Resources and Compensation · Chair; Science and Technology (member); Science and Technology (member). claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:16
- Sol J. Barer: Chairman of the Board. Status: current. Independent: true. Since: 2015-01-01. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:8
- Tal Zaks: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:17
## Committees
- Audit (audit). Chair: Gerald Lieberman. Members: Gerald Lieberman (chair, current); Amir Elstein (member, current); Chen Lichtenstein (member, current); Roberto Mignone (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:audit
- Audit · Chair; Human Resources and Compensation; Finance and Investment (audit). Chair: NOT_PUBLISHED. Members: Gerald Lieberman (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:audit-chair-human-resources-and-compensation-finance-and-investment
- Audit; Compliance; Finance and Investment (audit). Chair: NOT_PUBLISHED. Members: Chen Lichtenstein (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:audit-compliance-finance-and-investment
- Compliance (other). Chair: NOT_PUBLISHED. Members: Chen Lichtenstein (member, current); Perry D. Nisen (member, current); Prof. Ronit Satchi-Fainaro (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:compliance
- Compliance; Science and Technology; Corporate Governance and Nominating (nominating_governance). Chair: NOT_PUBLISHED. Members: Prof. Ronit Satchi-Fainaro (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:compliance-science-and-technology-corporate-governance-and-nominating
- Corporate Governance and Nominating (nominating_governance). Chair: Roberto Mignone. Members: Roberto Mignone (chair, current); Amir Elstein (member, current); Prof. Ronit Satchi-Fainaro (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating
- Corporate Governance and Nominating · Chair; Finance and Investment; Audit (audit). Chair: NOT_PUBLISHED. Members: Roberto Mignone (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating-chair-finance-and-investment-audit
- Corporate Governance and Nominating; Audit; Finance and Investment (audit). Chair: NOT_PUBLISHED. Members: Amir Elstein (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating-audit-finance-and-investment
- Finance and Investment (finance). Chair: NOT_PUBLISHED. Members: Amir Elstein (member, current); Chen Lichtenstein (member, current); Gerald Lieberman (member, current); Roberto Mignone (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:finance-and-investment
- Human Resources and Compensation (compensation). Chair: Rosemary A. Crane. Members: Rosemary A. Crane (chair, current); Gerald Lieberman (member, current); Perry D. Nisen (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:human-resources-and-compensation
- Human Resources and Compensation · Chair; Science and Technology (compensation). Chair: NOT_PUBLISHED. Members: Rosemary A. Crane (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:human-resources-and-compensation-chair-science-and-technology
- Science and Technology (technology). Chair: NOT_PUBLISHED. Members: Perry D. Nisen (member, current); Prof. Ronit Satchi-Fainaro (member, current); Rosemary A. Crane (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:science-and-technology
- Science and Technology; Compliance; Human Resources and Compensation (compensation). Chair: NOT_PUBLISHED. Members: Perry D. Nisen (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:science-and-technology-compliance-human-resources-and-compensation
## Executive leadership
- Amir Weiss: Senior VP & Chief Accounting Officer [CAO]. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:18
- Christopher J. Stevo: Senior Vice President of Investor Relations & Competitive Intelligence. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:19
- David R. Mcavoy: Executive VP & Chief Legal Officer [GC]. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:20
- Eliyahu Sharon Kalif: Executive VP & CFO [CFO]. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:21
- Eric A. Hughes: Executive Vice President of Global R&D and Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:22
- Kathleen Veit: Senior Vice President, Global Compliance & Ethics Officer. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:23
- Matthew Shields: Executive Vice President of Global Operations. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:24
- Richard Francis: President, Chief Executive Officer & Director [CEO]. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:25
- Richard Gordon Daniell: Executive Vice President of European Commercial. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:26
## Governance events
- DIRECTOR_APPOINTED: Chen Lichtenstein seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1qkxtil12pt8n5
- COMMITTEE_CREATED: Audit; Compliance; Finance and Investment committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1yh4sqr1ttoctp
- COMMITTEE_MEMBER_ADDED: Chen Lichtenstein member of Audit; Compliance; Finance and Investment, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1wcs26tl5612v
- DIRECTOR_APPOINTED: Richard Francis seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:16il4pua3nihm
- DIRECTOR_APPOINTED: Tal Zaks seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1qjua7njwulnn
- DIRECTOR_APPOINTED: Prof. Ronit Satchi-Fainaro seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1pmydy3154cqy1
- COMMITTEE_CREATED: Compliance; Science and Technology; Corporate Governance and Nominating committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:amafiv18a3vuh
- COMMITTEE_MEMBER_ADDED: Prof. Ronit Satchi-Fainaro member of Compliance; Science and Technology; Corporate Governance and Nominating, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:gkw9k01d66ric
- DIRECTOR_APPOINTED: Perry D. Nisen seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1mrevx1wuiunr
- DIRECTOR_APPOINTED: Roberto Mignone seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:115afeo15dpnok
- COMMITTEE_CREATED: Corporate Governance and Nominating · Chair; Finance and Investment; Audit committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:11znebih1wwnc
- COMMITTEE_MEMBER_ADDED: Roberto Mignone member of Corporate Governance and Nominating · Chair; Finance and Investment; Audit, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1i25mb6g79rtu
- COMMITTEE_CREATED: Science and Technology; Compliance; Human Resources and Compensation committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1wchka51xrdkqv
- COMMITTEE_MEMBER_ADDED: Perry D. Nisen member of Science and Technology; Compliance; Human Resources and Compensation, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:128sitl13fd4jj
- DIRECTOR_APPOINTED: Gerald Lieberman seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1ovsdeg1ie5ymm
- DIRECTOR_APPOINTED: Rosemary A. Crane seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:szo76d14d78it
- DIRECTOR_APPOINTED: Sol J. Barer seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:asbc54r2q4wu
- BOARD_CHAIR_CHANGED: Sol J. Barer chairs board TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1ue1iyg3h291q
- COMMITTEE_CREATED: Audit · Chair; Human Resources and Compensation; Finance and Investment committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:ib1mkg6zr5xi
- COMMITTEE_MEMBER_ADDED: Gerald Lieberman member of Audit · Chair; Human Resources and Compensation; Finance and Investment, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:qthtw71fbayw9
- COMMITTEE_CREATED: Human Resources and Compensation · Chair; Science and Technology committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:u1q349muv71x
- COMMITTEE_MEMBER_ADDED: Rosemary A. Crane member of Human Resources and Compensation · Chair; Science and Technology, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:4ealy1szuse9
- DIRECTOR_APPOINTED: Amir Elstein seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1luawxm36983q
- COMMITTEE_CREATED: Corporate Governance and Nominating; Audit; Finance and Investment committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:asgttw1ggs4a2
- COMMITTEE_MEMBER_ADDED: Amir Elstein member of Corporate Governance and Nominating; Audit; Finance and Investment, effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1hymqu81ctsfl0
## Scoped resources
- `alpha://company/teva-pharmaceutical-industries-ltd` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record
- `alpha://company/teva-pharmaceutical-industries-ltd/identity` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=identity
- `alpha://company/teva-pharmaceutical-industries-ltd/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=corporate-structure
- `alpha://company/teva-pharmaceutical-industries-ltd/board` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=board
- `alpha://company/teva-pharmaceutical-industries-ltd/committees` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=committees
- `alpha://company/teva-pharmaceutical-industries-ltd/leadership` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=leadership
- `alpha://company/teva-pharmaceutical-industries-ltd/ownership` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=ownership
- `alpha://company/teva-pharmaceutical-industries-ltd/financials` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=financials
- `alpha://company/teva-pharmaceutical-industries-ltd/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=capital-structure
- `alpha://company/teva-pharmaceutical-industries-ltd/compensation` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=compensation
- `alpha://company/teva-pharmaceutical-industries-ltd/governance` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=governance
- `alpha://company/teva-pharmaceutical-industries-ltd/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=shareholder-governance
- `alpha://company/teva-pharmaceutical-industries-ltd/audit` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=audit
- `alpha://company/teva-pharmaceutical-industries-ltd/legal` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=legal
- `alpha://company/teva-pharmaceutical-industries-ltd/risk` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=risk
- `alpha://company/teva-pharmaceutical-industries-ltd/cyber` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=cyber
- `alpha://company/teva-pharmaceutical-industries-ltd/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=ai-governance
- `alpha://company/teva-pharmaceutical-industries-ltd/agents` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=agents
- `alpha://company/teva-pharmaceutical-industries-ltd/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=ecosystem
- `alpha://company/teva-pharmaceutical-industries-ltd/events` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=events
- `alpha://company/teva-pharmaceutical-industries-ltd/relationships` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=relationships
- `alpha://company/teva-pharmaceutical-industries-ltd/assessments` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=assessments
- `alpha://company/teva-pharmaceutical-industries-ltd/evidence` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=evidence
## Role modules
- NOT_ASSERTED
## Attention
- NO_RECORDS_FOUND
## Committee data
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:gerald-lieberman","name":"Gerald Lieberman"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:amir-elstein","name":"Amir Elstein"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:chen-lichtenstein","name":"Chen Lichtenstein"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:roberto-mignone","name":"Roberto Mignone"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:33: `{"kind":"committee_appointment","original_name":"Compliance","category":"other","role":"member","person":{"alpha_id":"alpha:person:chen-lichtenstein","name":"Chen Lichtenstein"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:34: `{"kind":"committee_appointment","original_name":"Compliance","category":"other","role":"member","person":{"alpha_id":"alpha:person:perry-d-nisen","name":"Perry D. Nisen"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:35: `{"kind":"committee_appointment","original_name":"Compliance","category":"other","role":"member","person":{"alpha_id":"alpha:person:prof-ronit-satchi-fainaro-tevjf","name":"Prof. Ronit Satchi-Fainaro"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:37: `{"kind":"committee_appointment","original_name":"Corporate Governance and Nominating","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:roberto-mignone","name":"Roberto Mignone"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:38: `{"kind":"committee_appointment","original_name":"Corporate Governance and Nominating","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:amir-elstein","name":"Amir Elstein"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:39: `{"kind":"committee_appointment","original_name":"Corporate Governance and Nominating","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:prof-ronit-satchi-fainaro-tevjf","name":"Prof. Ronit Satchi-Fainaro"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:41: `{"kind":"committee_appointment","original_name":"Finance and Investment","category":"other","role":"member","person":{"alpha_id":"alpha:person:amir-elstein","name":"Amir Elstein"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:42: `{"kind":"committee_appointment","original_name":"Finance and Investment","category":"other","role":"member","person":{"alpha_id":"alpha:person:chen-lichtenstein","name":"Chen Lichtenstein"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:43: `{"kind":"committee_appointment","original_name":"Finance and Investment","category":"other","role":"member","person":{"alpha_id":"alpha:person:gerald-lieberman","name":"Gerald Lieberman"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:44: `{"kind":"committee_appointment","original_name":"Finance and Investment","category":"other","role":"member","person":{"alpha_id":"alpha:person:roberto-mignone","name":"Roberto Mignone"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:46: `{"kind":"committee_appointment","original_name":"Human Resources and Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:rosemary-a-crane","name":"Rosemary A. Crane"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:47: `{"kind":"committee_appointment","original_name":"Human Resources and Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:gerald-lieberman","name":"Gerald Lieberman"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:48: `{"kind":"committee_appointment","original_name":"Human Resources and Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:perry-d-nisen","name":"Perry D. Nisen"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:50: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"member","person":{"alpha_id":"alpha:person:perry-d-nisen","name":"Perry D. Nisen"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:51: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"member","person":{"alpha_id":"alpha:person:prof-ronit-satchi-fainaro-tevjf","name":"Prof. Ronit Satchi-Fainaro"},"source_id":"board_seats"}`
- Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:52: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"member","person":{"alpha_id":"alpha:person:rosemary-a-crane","name":"Rosemary A. Crane"},"source_id":"board_seats"}`
## Leadership
- Sol J. Barer: Chairman of the Board. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:8. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069.
- Amir Elstein: Director, Corporate Governance and Nominating; Audit; Finance and Investment. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:9. Valid from: 2009-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3.
- Chen Lichtenstein: Director, Audit; Compliance; Finance and Investment. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:10. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3.
- Gerald Lieberman: Director, Audit · Chair; Human Resources and Compensation; Finance and Investment. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:11. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3.
- Perry D. Nisen: Director, Science and Technology; Compliance; Human Resources and Compensation. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:12. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3.
- Prof. Ronit Satchi-Fainaro: Director, Compliance; Science and Technology; Corporate Governance and Nominating. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:13. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069.
- Richard Francis: Director. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:14. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3.
- Roberto Mignone: Director, Corporate Governance and Nominating · Chair; Finance and Investment; Audit. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:15. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3.
- Rosemary A. Crane: Director, Human Resources and Compensation · Chair; Science and Technology. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:16. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3.
- Tal Zaks: Director. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:17. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3.
- Amir Weiss: Senior VP & Chief Accounting Officer. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b35f77c27991bb5d53fb217d5341760f27e8ef78affed273ecede8c8ad564834.
- Christopher J. Stevo: Senior Vice President of Investor Relations & Competitive Intelligence. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3127308aa3cb1944dab9fc50df63e4750f721ac8840ba756fd276d7455831faa.
- David R. Mcavoy: Executive VP & Chief Legal Officer. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bedb35712599178b10aaea6d30b7f48140f30ad5a489d8713f6a88171b29f5e2.
- Eliyahu Sharon Kalif: Executive VP & CFO. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6db10fc291abc3f16e22c4ed40ca600b9de6cc382722b58fa8aa8792d0ee3a4b.
- Eric A. Hughes: Executive Vice President of Global R&D and Chief Medical Officer. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2cfd57eb48fbc6e6cdb965ef825ffb62cb6e774aaa649b7c81c75212c2c163a1.
- Kathleen Veit: Senior Vice President, Global Compliance & Ethics Officer. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:31e2475c90141d450c3ea7e98f59c770cc5891862868c22b4b4d49f78153f110.
- Matthew Shields: Executive Vice President of Global Operations. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2cd73c5146f224c38031862cb66c63314661926134e851ee01c2070e1334c9f8.
- Richard Francis: President, Chief Executive Officer & Director. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:25b799e360910f8efe7c2a8d628d7396d74d0f78b80711428ba596e7f078a8e0.
- Richard Gordon Daniell: Executive Vice President of European Commercial. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f847a8f21246910909e2a4e3b942bcbde32f052cba0510177821ccd7de82a59b.
## Roles
- PUBLISHED
## Governance
- NOT_ASSERTED
## Board committees
- Audit: Chair Gerald Lieberman; Members Gerald Lieberman (Chair); Amir Elstein; Chen Lichtenstein; Roberto Mignone. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Compliance: Chair not stated; Members Chen Lichtenstein; Perry D. Nisen; Prof. Ronit Satchi-Fainaro. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Corporate Governance and Nominating: Chair Roberto Mignone; Members Roberto Mignone (Chair); Amir Elstein; Prof. Ronit Satchi-Fainaro. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:36. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Finance and Investment: Chair not stated; Members Amir Elstein; Chen Lichtenstein; Gerald Lieberman; Roberto Mignone. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:40. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Human Resources and Compensation: Chair Rosemary A. Crane; Members Rosemary A. Crane (Chair); Gerald Lieberman; Perry D. Nisen. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:45. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Science and Technology: Chair not stated; Members Perry D. Nisen; Prof. Ronit Satchi-Fainaro; Rosemary A. Crane. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:49. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
## Financials
- NOT_ASSERTED
## Workforce
- NOT_ASSERTED
## Market and index context
- PUBLISHED
## Legal Name
- TEVA PHARMACEUTICAL INDUSTRIES LTD. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723.
## Entity Status
- Public listing published. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723.
## Published Fact
- US. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723.
- IL. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723.
- Healthcare. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:published_fact:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723.
## Committee Appointment
- Gerald Lieberman: chair, Audit. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Amir Elstein: member, Audit. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Chen Lichtenstein: member, Audit. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Roberto Mignone: member, Audit. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Chen Lichtenstein: member, Compliance. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Perry D. Nisen: member, Compliance. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Prof. Ronit Satchi-Fainaro: member, Compliance. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Roberto Mignone: chair, Corporate Governance and Nominating. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:37. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Amir Elstein: member, Corporate Governance and Nominating. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:38. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Prof. Ronit Satchi-Fainaro: member, Corporate Governance and Nominating. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:39. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Amir Elstein: member, Finance and Investment. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:41. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Chen Lichtenstein: member, Finance and Investment. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:42. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Gerald Lieberman: member, Finance and Investment. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:43. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Roberto Mignone: member, Finance and Investment. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:44. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Rosemary A. Crane: chair, Human Resources and Compensation. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:46. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Gerald Lieberman: member, Human Resources and Compensation. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:47. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Perry D. Nisen: member, Human Resources and Compensation. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:48. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Perry D. Nisen: member, Science and Technology. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:50. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Prof. Ronit Satchi-Fainaro: member, Science and Technology. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:51. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
- Rosemary A. Crane: member, Science and Technology. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:52. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60.
## Security Listing
- TEVA (NYSE). Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:security_listing:53. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723.
- TEVA (TASE). Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:security_listing:54. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723.
- TEVJF (OTC). Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:security_listing:55. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723.
## Coverage states
| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
## Public sources
- alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd).
- alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069: [DEF 14A d11454ddef14a.htm](https://www.sec.gov/Archives/edgar/data/818686/000119312524097745/d11454ddef14a.htm).
- alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3: [DEF 14A d11977ddef14a.htm](https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm).
- alpha:projection-evidence:document:b35f77c27991bb5d53fb217d5341760f27e8ef78affed273ecede8c8ad564834: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA).
- alpha:projection-evidence:document:3127308aa3cb1944dab9fc50df63e4750f721ac8840ba756fd276d7455831faa: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA).
- alpha:projection-evidence:document:bedb35712599178b10aaea6d30b7f48140f30ad5a489d8713f6a88171b29f5e2: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA).
- alpha:projection-evidence:document:6db10fc291abc3f16e22c4ed40ca600b9de6cc382722b58fa8aa8792d0ee3a4b: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA).
- alpha:projection-evidence:document:2cfd57eb48fbc6e6cdb965ef825ffb62cb6e774aaa649b7c81c75212c2c163a1: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA).
- alpha:projection-evidence:document:31e2475c90141d450c3ea7e98f59c770cc5891862868c22b4b4d49f78153f110: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA).
- alpha:projection-evidence:document:2cd73c5146f224c38031862cb66c63314661926134e851ee01c2070e1334c9f8: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA).
- alpha:projection-evidence:document:25b799e360910f8efe7c2a8d628d7396d74d0f78b80711428ba596e7f078a8e0: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA).
- alpha:projection-evidence:document:f847a8f21246910909e2a4e3b942bcbde32f052cba0510177821ccd7de82a59b: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA).
- alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60: [Audit](https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm).
## Rights
| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
## Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
## Alternate representations
- [Canonical profile](https://registry.alpha.ac/companies/teva-pharmaceutical-industries-ltd)
- [Public Markdown](https://registry.alpha.ac/companies/teva-pharmaceutical-industries-ltd.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=jsonld)
- MCP resource: `alpha://companies/teva-pharmaceutical-industries-ltd` at https://mcp.alpha.ac/mcp
## Connected governance records
Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.
## Critical-risk oversight
Snapshot as of 2026-10-24T23:42:38.095989+00:00; recorded 2026-10-24T23:42:38.095989+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.TEVA PHARMACEUTICAL INDUSTRIES LTD, for agents
The same record as the human view, as a structured object any agent can read and cite. Reading is open to every agent, model, and tool, with no key and no account. Signing and transparency logging are not yet published for this record.
- Alpha ID
- alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050
- Version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ceRecorded Oct 24, 2026
- Content hash
- Not yet signed
- Signature
- Not yet signed
- Transparency log
- Not yet signed
- Freshness
- ObservedChecked Oct 24, 2026. Reviewed Oct 24, 2026
- Read access
- OpenNo key for public retrieval
- Processing basis
- Public recordDoctrine
Read
OpenOne canonical URL. The Accept header or a file suffix selects the format. Every format renders the same Claims and carries the same record version.
curl -H "Accept: application/json" https://registry.alpha.ac/companies/teva-pharmaceutical-industries-ltdTrustCheck and Governance Receipts
Agent tierIllustrative. TrustChecks run in the private enterprise overlay. The example below is generated for this entity class and does not reference this record. Contract: TrustCheck and Governance Receipts v0.1.
Agents about to act ask a question, not for a document. A TrustCheck evaluates the AuthorityGrant objects behind a proposed action and returns allow, deny, require_approval, or insufficient_evidence. The source system acts, and a GovernanceReceipt records what the agent relied on.
- allow, deny
- The AuthorityGrant and policy decide. Reason codes name the rule.
- require_approval
- An entitled human records the decision. Customer policy sets the threshold, never an Eval.
- insufficient_evidence
- No authority is registered. Alpha never infers permission to act.
curl https://www.alpha.ac/v1/action-intents \
-H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" \
-d '{
"schema_version": "2026-08-29",
"environment": "test",
"actor": { "alpha_id": "alpha:account:self", "type": "alpha_account" },
"principal": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"organization": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"proposed_action": { "type": "purchase_order.commit", "description": "Accept an order placed by an agent claiming company authority." },
"requested_authority": ["purchase_order.commit"]
}'
# then
curl https://www.alpha.ac/v1/trust-checks -H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" -d '{ "action_intent_id": "<from the previous response>" }'{
"schema_version": "2026-08-29",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"decision": "insufficient_evidence",
"explanation": "No AuthorityGrant names this agent and organization.",
"reason_codes": [
"authority_grant_missing"
],
"evaluated_authority": {
"authority_grants": []
},
"policy_version": "trustcheck.registry-claim.test.v0.1",
"integrity_state": "recorded",
"limitations": [
"Illustrative example. No TrustCheck was run for this record."
]
}{
"schema_version": "2026-08-29",
"receipt_id": "alpha:receipt:illustrative-0001",
"environment": "test",
"actor": {
"alpha_id": "alpha:account:self",
"type": "alpha_account"
},
"agent": {
"provider": {
"alpha_id": "alpha:company:example-agent-provider",
"type": "provider"
},
"product": {
"alpha_id": "alpha:agent-product:example-procurement-agent",
"type": "agent_product"
},
"deployment": {
"alpha_id": "alpha:agent-deployment:example-deployment",
"type": "agent_deployment"
},
"use_case": {
"alpha_id": "alpha:agent-use-case:example-purchase-order",
"type": "agent_use_case"
},
"workflow": "Illustrative purchase order commitment"
},
"principal": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"sponsor": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"action_intent_id": "alpha:action-intent:illustrative-0001",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"authority_grant_references": [],
"action_intent": {
"type": "purchase_order.commit"
},
"affected_alpha_ids": [
"alpha:company:example-issuer"
],
"trust_check_decision": "insufficient_evidence",
"policy_version": "trustcheck.registry-claim.test.v0.1",
"rule_references": [
{
"reason_code": "authority_grant_missing",
"rule_id": "trustcheck.authority_grant_missing",
"policy_ref": "trustcheck.registry-claim.test.v0.1",
"control_ref": null,
"grant_policy_references": []
}
],
"integrity": "Illustrative. Not issued, not signed."
}Connect
Open readEvery surface reads the same published record. No surface holds its own copy of the facts.
// claude_desktop_config.json, Cursor, or any MCP client
{
"mcpServers": {
"alpha": { "url": "https://mcp.alpha.ac/mcp" }
}
}
// This record as an MCP resource
alpha://companies/teva-pharmaceutical-industries-ltdalpha://companies/teva-pharmaceutical-industries-ltdThis record as an MCP resourcehttps://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=recordThe same record over HTTP
Subscribe to changes
Agent tier, previewNo public subscription endpoint is published yet. Event delivery is part of Agent tier access, in preview. Access and availability.
DIRECTOR_APPOINTEDDerived governance event published on this record (alpha-governance-event-derivation-v2)COMMITTEE_CREATEDDerived governance event published on this record (alpha-governance-event-derivation-v2)COMMITTEE_MEMBER_ADDEDDerived governance event published on this record (alpha-governance-event-derivation-v2)BOARD_CHAIR_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)
{
"specversion": "1.0",
"type": "ac.alpha.registry.DIRECTOR_APPOINTED",
"source": "https://registry.alpha.ac/companies/teva-pharmaceutical-industries-ltd",
"subject": "alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050",
"data": {
"record_version": "public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce",
"note": "Subscription delivery is Agent tier, preview. Not yet available publicly."
}
}Versions and changes
OpenRecords are versioned. Derived governance events on this record are listed below with the version that publishes them. Effective is the world time the derivation states; Recorded is when Alpha detected the event. Content hashes and log entries appear once records are signed.
| Version | Effective | Recorded | Content hash | Log entry | What changed |
|---|---|---|---|---|---|
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2024 | Oct 24, 2026 | Not yet signed | Not yet signed | Chen Lichtenstein seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2024-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2024 | Oct 24, 2026 | Not yet signed | Not yet signed | Audit; Compliance; Finance and Investment committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2024-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2024 | Oct 24, 2026 | Not yet signed | Not yet signed | Chen Lichtenstein member of Audit; Compliance; Finance and Investment, effective 2024-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2023 | Oct 24, 2026 | Not yet signed | Not yet signed | Richard Francis seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2023-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2021 | Oct 24, 2026 | Not yet signed | Not yet signed | Tal Zaks seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2021-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2018 | Oct 24, 2026 | Not yet signed | Not yet signed | Prof. Ronit Satchi-Fainaro seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2018-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2018 | Oct 24, 2026 | Not yet signed | Not yet signed | Compliance; Science and Technology; Corporate Governance and Nominating committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2018-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2018 | Oct 24, 2026 | Not yet signed | Not yet signed | Prof. Ronit Satchi-Fainaro member of Compliance; Science and Technology; Corporate Governance and Nominating, effective 2018-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 24, 2026 | Not yet signed | Not yet signed | Perry D. Nisen seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 24, 2026 | Not yet signed | Not yet signed | Roberto Mignone seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 24, 2026 | Not yet signed | Not yet signed | Corporate Governance and Nominating · Chair; Finance and Investment; Audit committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 24, 2026 | Not yet signed | Not yet signed | Roberto Mignone member of Corporate Governance and Nominating · Chair; Finance and Investment; Audit, effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 24, 2026 | Not yet signed | Not yet signed | Science and Technology; Compliance; Human Resources and Compensation committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 24, 2026 | Not yet signed | Not yet signed | Perry D. Nisen member of Science and Technology; Compliance; Human Resources and Compensation, effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2015 | Oct 24, 2026 | Not yet signed | Not yet signed | Gerald Lieberman seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2015 | Oct 24, 2026 | Not yet signed | Not yet signed | Rosemary A. Crane seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2015 | Oct 24, 2026 | Not yet signed | Not yet signed | Sol J. Barer seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2015 | Oct 24, 2026 | Not yet signed | Not yet signed | Sol J. Barer chairs board TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2015 | Oct 24, 2026 | Not yet signed | Not yet signed | Audit · Chair; Human Resources and Compensation; Finance and Investment committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2015 | Oct 24, 2026 | Not yet signed | Not yet signed | Gerald Lieberman member of Audit · Chair; Human Resources and Compensation; Finance and Investment, effective 2015-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2015 | Oct 24, 2026 | Not yet signed | Not yet signed | Human Resources and Compensation · Chair; Science and Technology committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2015 | Oct 24, 2026 | Not yet signed | Not yet signed | Rosemary A. Crane member of Human Resources and Compensation · Chair; Science and Technology, effective 2015-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2009 | Oct 24, 2026 | Not yet signed | Not yet signed | Amir Elstein seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2009-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2009 | Oct 24, 2026 | Not yet signed | Not yet signed | Corporate Governance and Nominating; Audit; Finance and Investment committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2009-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2009 | Oct 24, 2026 | Not yet signed | Not yet signed | Amir Elstein member of Corporate Governance and Nominating; Audit; Finance and Investment, effective 2009-01-01. |
Access, rights, and the public-role doctrine
Facts are open. Rights travel with every Claim and every Evidence record, so an agent sees the same terms whichever format it reads.
| Capability | Access | Agents |
|---|---|---|
| Alpha Disclosure sample | public | human process |
| Alpha public website | public | retrievable now |
| Alpha Standard, methodology, and research | public | retrievable now |
| Alpha Profiles (public executive and company records) | public | retrievable now |
| Public HTTP endpoints described by OpenAPI 3.1 | public | retrievable now |
| Alpha MCP public discovery and read-only capabilities | public | retrievable now |
| Alpha AI Readiness Eval | public | human process |
| Alpha Platform | approved access | requires approved access |
| Alpha API (authenticated operations) | approved access | requires approved access |
| Alpha MCP premium capabilities | approved access | requires approved access |
| Alpha Evals and verified assessments | custom | human process |
| Alpha Council membership | custom | human process |
| Alpha Institute education, workshops, and coaching | custom | human process |
| Governance diagnostics and institutional advisory | custom | human process |
Record limitations. Every representation states these in the same words; nothing is inferred as zero.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
}
"evidence_rights": {
"evidence_records": 13,
"redistribution_allowed": 0,
"restricted_or_unknown": 13,
"classified_unknown": 13
}"data_subject": {
"basis": "public_record",
"entity": "alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050",
"identity_ownership": "unclaimed",
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
},
"requests": "https://www.alpha.ac/contact"
}How agents find this
OpenThe page head and every response carry rel="alternate" links and the Registry's Link header. The list below is generated from the same list the server emits.
/llms-full.txtAlpha consolidated public agent guide/.well-known/ai-catalog.jsonAlpha Agentic Resource Discovery manifest/.well-known/api-catalogapi-catalog/.well-known/webmcp.jsonAlpha WebMCP tool discovery/openapi.jsonAlpha Governance Public Intelligence API (OpenAPI 3.1)/apiAlpha Intelligence API/developersAlpha Governance Developer Platform/docs/trustcheck-receipts-v01.mdTrustCheck and Governance Receipts v0.1 test preview/docs/apiAlpha service documentation/llms.txtAlpha service docs for AI agents/agents.mdAlpha agent instructions (when to use Alpha)/api-versioning.mdAlpha public API versioning and deprecation policy/.well-known/agent-skills/index.jsonAgent Skills Index/products/accessAlpha Access and Availability/api/public/product-accessAlpha Product Access and Availability JSON/api/public/auth-capabilitiesAlpha Authentication Capabilities JSON/peopleAlpha Executive Profiles/companiesAlpha Company Profiles/people/readinessAlpha Profile Coverage and Agent Readiness/api/public/profile-readinessAlpha Public Profile Readiness JSON/api/public/profiles/steven-wolfe-pereiraAlpha Public Profile JSON Example/.well-known/agent-card.jsonA2A Agent Card/.well-known/mcp/server-card.jsonMCP Server Card/.well-known/openid-configurationOpenID Configuration/.well-known/oauth-protected-resourceOAuth Protected Resource/.well-known/oauth-authorization-serverOAuth Authorization Server (agent_auth)/.well-known/agent-registrationAgent Registration/.well-known/http-message-signatures-directoryhttp-message-signatures-directory/.well-known/jwks-rotationJWKS Rotation Policy/auth.mdAgent Authentication/llms.txtSite overview for AI agents/sitemap.xmlsitemap/api/public/agent-readinessAgent Readiness Status/api/public/company-report/osw-market-dataOSW Market Data Verification
Record map and assertion states
| Section | Anchor | Resource | State | Claims |
|---|---|---|---|---|
| Identity | #c-subject | /identity | Published | 0 |
| Corporate structure | - | /corporate_structure | Not reviewed | - |
| Board | #c-board | /board | Published | 11 |
| Committees | #c-committees | /committees | Published | 26 |
| Leadership | #c-leadership | /leadership | Published | 8 |
| Ownership | #c-control | /ownership | Not reviewed | 0 |
| Financials | #c-financials | /financials | Not reviewed | 3 |
| Capital structure | - | /capital_structure | Published | - |
| Compensation | #c-comp | /compensation | Not reviewed | 0 |
| Governance | #c-governance | /governance | Not reviewed | 0 |
| Shareholder governance | - | /shareholder_governance | Not reviewed | - |
| Audit | - | /audit | Not reviewed | - |
| Legal | #c-legal | /legal | Not reviewed | 0 |
| Risk | #c-risk | /risk | Not reviewed | 0 |
| Cyber | - | /cyber | Not reviewed | - |
| AI governance | #c-ai | /ai_governance | Not reviewed | 0 |
| Agent governance | #c-authority | /agent_governance | Restricted | 0 |
| Markets external | - | /markets_external | Not reviewed | - |
| Events | #c-history | /events | Published | 25 |
| Relationships | #c-links | /relationships | Published | 19 |
| Assessments | #c-monitor | /assessments | Published | 0 |
| Evidence | #c-evidence | /evidence | Published | 13 |
- corroboratedTwo or more independent sources agree
- source_reportedOne cited source states it
- alpha_inferenceAlpha's conclusion, with reasoning
- not_disclosedSearched, nothing found. Never rendered as false
- not_reviewedNot yet searched
- not_registeredNo authority registered with Alpha

